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Abstract
Background: Open-angle glaucoma appears to be induced by the malfunction of the trabecular meshwork cells due to
injury induced by oxidative damage and mitochondrial impairment. Here, we report that, in fact, we have detected
mitochondrial damage only in primary open-angle glaucoma and pseudo-exfoliation glaucoma, among several glaucoma
types compared.
Methodology/Principal Findings: Mitochondrial damage was evaluated by analyzing the common mitochondrial DNA
deletion by real-time PCR in trabecular meshwork specimens collected at surgery from glaucomatous patients and controls.
Glaucomatous patients included 38 patients affected by various glaucoma types: primary open-angle, pigmented, juvenile,
congenital, pseudoexfoliative, acute, neovascular, and chronic closed-angle glaucoma. As control samples, we used 16
specimens collected from glaucoma-free corneal donors. Only primary open-angle glaucoma (3.0-fold) and pseudoexfo-
liative glaucoma (6.3-fold) showed significant increases in the amount of mitochondrial DNA deletion. In all other cases,
deletion was similar to controls.
Conclusions/Significance: Despite the fact that the trabecular meshwork is the most important tissue in the
physiopathology of aqueous humor outflow in all glaucoma types, the present study provides new information regarding
basic physiopathology of this tissue: only in primary open-angle and pseudoexfoliative glaucomas oxidative damage arising
from mitochondrial failure play a role in the functional decay of trabecular meshwork.
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Introduction
Glaucoma is a neurodegenerative eye disease, the affected
regions of which are (a) the retina, particularly the optic nerve; (b)
the central nervous system, especially the lateral geniculate nucleus
of the brain [1]; and (c) the eye anterior chamber, specifically the
trabecular meshwork (TM). TM is crucial in glaucoma pathogen-
esis because its malfunction causes intraocular pressure (IOP)
increases, as occur during open-angle glaucoma [2]. Indeed, TM
cellularity, in particular the number of endothelial cells, plays a
fundamental role in regulating the passage of fluids from the
anterior chamber (AC) to Schlemm’s canal [3]. Moreover, TM
endothelial cells regulate the permeability of endothelial cells in
Schlemm’s canal, giving them a major role in the regulation of
aqueous outflow [4]. The number of TM endothelial cells
decreases with age [5]. During a patient’s lifetime, TM cells are
constantly exposed by free radicals in the AC, where a precarious
balance between antioxidant defenses and oxidative free radicals
exists [6]. Free radicals and reactive oxygen species are able to
affect the cellularity of the human TM (HTM). These findings
suggest that an intraocular pressure increase, which characterizes
most glaucomas, is related to oxidative and degenerative processes
affecting the HTM and, more specifically, its endothelial cells [7].
Furthermore, HTM is more sensitive to oxidative stress than other
tissues around the AC [8]. Indeed, oxidative damage caused by
reactive oxygen species (ROS) is greater in primary open-angle
glaucoma (POAG) and pseudoexfoliative glaucoma (PEXG)
patients than in healthy subjects [9]. TM endothelial cells secrete
a number of factors, such as enzymes and cytokines, which
modulate the functions of the cells and the extracellular matrix of
the conventional aqueous outflow pathway [10] Damage to TM
endothelial cells causes malfunction in the homeostasis of the
outflow of the aqueous humor. The exact molecular mechanism
underlying TM cell loss in glaucoma patients is still unclear.
Indeed, chronic oxidative stress leads to the endogenous
production of ROS by mitochondria in TM cells, thereby
increasing the level of oxidative damage in the tissue [11]. In
glaucomatous patients, a spectrum of mitochondrial abnormalities
involving oxidative stress and implying mitochondrial dysfunction
has been found [12]. The composition of aqueous humor proteins
changes dramatically [13], and antioxidant proteins undergo
down-regulation, in glaucoma; this leads to increased concentra-
tions of nitric oxide synthase 2 and other proteins that, in
physiological conditions, are segregated inside the functional
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specific DNA of maternal origin, mitochondrial DNA (mtDNA).
This encodes only 13 structural proteins, all of which are involved
in the respiratory chain. Most mitochondrial proteins are encoded
by nuclear DNA. A complex interaction between the two genomes
is therefore at the basis of mitochondrial protein synthesis and of
mtDNA replication [15]. Mitochondria produce up to 90% of the
cellular energy and also play a critical role in mediating cell death
through the apoptotic pathway [16]. Damage accruing to the
mitochondrial genome is associated with increased cellular stress
and organelle dysfunction [17]. He and colleagues showed that
TM cells of patients with POAG undergo ATP diminution, as
their functionality is endangered by an intrinsic mitochondrial
complex I defect, causing a respiratory chain deficit in these cells
[18]. Recently, we reported that in TM of POAG patients, as
compared with control subjects, mtDNA deletion is dramatically
increased and the ratio between mtDNA and nuclear DNA is
reduced. The amount of nuclear DNA in relation to wet tissue
weight is also decreased [14]. These findings provide evidence that
mitochondrial damage is severe in the TM of POAG patients.
Besides POAG, many other glaucoma types exist, including
pigmented (PG), juvenile (JG), congenital (CG), acute closed-angle
(ACG), neovascular (NVG), and chronic closed-angle glaucoma
(CCAG), each one characterized by different and specific
pathogenic mechanisms. The aim of the present paper is to
establish whether there are biomolecular differences between
mtDNA deletions in POAG and those found in other glaucoma
types.
Results
The extent of mitochondrial DNA deletion in various glaucoma
types as detected by QPCR is reported in Figure 1. These findings
are paralleled by the amount of oxidative nuclear DNA damage
(8-hydroxy-29-deoxyguanosine) of the same samples by
32P-
postlabeling (Figure 1).
Furthermore, a variety of parameters reflecting the occurrence
of molecular alterations in mitochondria were considered,
including (a) %mtDNA deletion/mtDNA, which is the amount
of deleted mtDNA compared to total mtDNA and thus directly
expresses the extent of the 4977 mtDNA common lesion; (b) total
mtDNA/mg wet tissue, which represents the amount of
mitochondria in the analyzed TM biopsy; (c) total nDNA/mg
wet tissue, which represents the number of cells in the analyzed
TM biopsy. As reported in Table 1, only POAG and PEXG
showed a high level of mitochondrial deletion as compared to
controls. The mtDNA 4977 deletion values observed in PEXG
were more than double those detected in POAG.
In all glaucoma types other than POAG and PEXG, the
amount of mitochondrial deletion did not significantly vary from
that observed in control TM samples (Table 1).
Similar findings were obtained for oxidative damage to nuclear
DNA, which significantly increased only in POAG and PEXG and
not in other glaucoma types.
TM cellularity, expressed as total nDNA/mg wet tissue, was
dramatically decreased in all glaucoma types, indicating that cell
loss in TM is a non-specific event occurring in many glaucoma
types. Similarly, the total number of mitochondria in TM
decreased in all glaucoma types, a finding related to the cell loss
observed. Conversely, the number of mitochondria per cell
(mtDNA/nDNA ratio) was significantly decreased only in POAG
and PEXG (Table 1).
A non-significant trend towards a lower level of mtDNA
deletion in some glaucoma types (juvenile, congenital,) than in
controls was observed, probably due to the younger age of these
patients as compared to controls.
A significant correlation between the amount of mtDNA
deletion and the level of oxidative DNA damage detected in
different glaucoma types was observed (r=+0.942, P,0.001). This
finding indicates that mitochondrial damage is tightly correlated
with the development of oxidative damage in TM cells. A
significantly inverse relationship was observed between the
number of mitochondria per TM cell and oxidative damage
(r=20.780, P,0.05). This finding indicates that accumulation of
oxidative damage inside TM cells results in severe mitochondrial
loss.
Together, our results provide evidence of the strong connection
existing in TM between oxidative stress and mitochondrial
damage in degenerative forms of glaucoma (POAG and PEXG).
Discussion
Our results indicate that mitochondrial damage and related
oxidative stress specifically occur in POAG and PEXG and not in
other glaucoma types.
A high level of mitochondrial alterations was observed,
particularly in PEXG, which had the highest levels of mtDNA
deletion, oxidative nDNA damage, and mitochondrial loss per cell.
These results justify the clinical features of PEXG, which is more
aggressive than POAG and typically displays higher intraocular
pressure [19]; moreover, tonometric compensation is also more
difficult in PEXG.
These results indicate that POAG and PEXG are characterized
by specific mechanisms involving mitochondrial damage, oxidative
stress, and mitochondrial loss, finally resulting in TM cell loss.
Conversely, in other glaucoma types, TM cell loss is independent
of mitochondrial damage and loss.
The observed specific role of mitochondria damage in the
degenerative glaucomas (i.e., POAG and PEXG) is in line with the
important function of this organelle. Human cells depend on ATP
for growth, differentiation and responses to physiological and
environmental stimuli. Mitochondria are cytoplasmic organelles,
the main role of which is to synthesize ATP. They play crucial
roles in other cell processes, the most important of which include
development, calcium homeostasis, cell cycle regulation, thermo-
genesis, free radical production and apoptosis. The respiratory
chain is composed of five multiheteromeric enzymatic complexes
(I, II, III, IV and V) embedded in the inner membrane of
mitochondria. The respiratory chain is under the control of two
separate genetic systems, i.e. mtDNA and nDNA behaving
differently in many respects [20]. The mitochondrial genome
regularly replicates in postmitotic cells, about once per month.
The mitochondria divide mainly in response to the energy needs of
the cell, i.e., independently of the cell cycle [21]. The
mitochondria continuously fuse with one another, and the cells
may therefore contain both normal and possibly modified
mitochondrial genes. After cell division, the proportions of mutant
genomes differ in the individual descendant cells. The frequency
and proportion of the deleted mtDNA in human tissues increase
with age. mtDNA deletions occur more frequently and abundantly
in high energy-demanding tissues during the aging process [22].
mtDNA is more vulnerable to oxidative stress, its mutation rate
being about 10-fold higher than that of nDNA [23]. All tissues
from adult subjects show the presence of mitochondrial DNA
molecules with deletions [24], and the accumulation of mtDNA
mutations in aging contributes significantly to the decline of
mitochondrial energy production that characterizes the aging
process in many tissues [25–26].
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(ROS) increases, as do the by-products of aerobic metabolism in
aging tissues. Indeed, the mitochondrial respiratory chain is one of
the main sources of deleterious free radicals in the human
organism. Under normal physiological conditions, a small fraction
of the oxygen consumed by mitochondria is constantly converted
to superoxide anions, hydrogen peroxide, hydroxyl radicals and
other ROS [27]. The age-dependent decline in the capacity of
mitochondria to dispose of these oxy-radicals renders mtDNA
more vulnerable to mutations during the ageing process [28]. In
this light, the mtDNA deletions in the human TM that accumulate
during the aging process are the result of this reduced capability.
Mitochondrial decay, as evaluated by cytochrome c oxidase
analysis, is associated with apoptotic activation in TM cells in
patients with POAG [18], in that oxidative stress causes activation
of mitochondrial matrix caspase activity, which is secondary to
cytochrome c release [28]. In addition to the endogenous
formation and accumulation of mtDNA deletions in human
tissues during the normal aging process, physiological and
environmental factors such as light may also play important roles
Figure 1. Normalized QPCR evaluation of the common 4977-bp mtDNA deletion in TM of patients with different glaucoma types.
The horizontal axis shows the number of QPCR cycles, the vertical axis the amount of amplified DNA as inferred from the intensity of the fluorescence
signal. The continuous curve indicates the normalized quantity of total mtDNA, the dashed curve indicates the relative amount of 4977 bp–deleted
mtDNA. Samples in which the dashed curve intercepts the threshold horizontal line at lower QPCR cycles (left side) have a greater amount of
4977 bp–deleted mtDNA. For each sample, the box on the left shows oxidative nuclear DNA damage (8-oxo-dG) as detected by
32P-postlabeling.
doi:10.1371/journal.pone.0014567.g001
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[29]. Such mutations are induced through a similar mechanism as
the endogenous mutations, although the absolute extent of
accumulation differs among tissues [30]. Our results show that
the generalized relative abundance of particular mtDNA muta-
tions in specific tissues is associated with specific TM pathologies,
i.e., PEXG and POAG.
Exfoliation syndrome, associated with PEXG, is an age-related
disorder of the extracellular matrix characterized by the
production and progressive accumulation of a fibrillar material
not only in ocular tissues but also in skin and connective tissue
portions of various visceral organs. From a histopathological point
of view, PEXG is different from POAG. Whereas POAG is
characterized by increased juxtacanalicular plaque material and
decreased TM cellularity [5], in pseudoexfoliative glaucoma, both
plaque material and cellularity are unchanged compared with
normal eyes; the characteristic exfoliation material is deposited
instead [31]. Although these histopathological differences suggest
completely different pathogenetic mechanisms [32], our results
show that POAG and PEXG share one mechanism in common.
They both produce a decrease in TM cellularity through
mitochondrial damage and apoptosis, which is stimulated by the
ROS circulating in the AC and produced in TM by damaged
mitochondria. Oxidative DNA damage in pseudoexfoliative
patients is greater than that which occurs in POAG patients in
the TM region. However, the accumulation of locally produced
pseudoexfoliative material in the juxtacanalicular tissue, and the
consequent dysfunction of endothelial cells and disorganization of
juxtacanalicular tissue and Schlemm’s canal, are causative factors
in the development of a special type of secondary open-angle
glaucoma in exfoliation syndrome [31]. Decreased cellularity of
the trabecular meshwork appears to be a particular characteristic
of POAG, but other authors reported that it does not seem to play
a role in the pathogenesis of PEX glaucoma [31].
Interestingly, other types of glaucoma have not shown signs of
mitochondrial deletion increases. In neovascular glaucoma, the
TM is damaged by neo-vessels that invade the tissue, causing its
malfunctioning and increasing IOP. Indeed, if neovascularization
regresses, a rapid IOP decrease results [33]. Both chronic and
acute closed-angle glaucomas present structural similarities: pupil-
blocking force, status of angle synechia closure, and shallow depth
of the anterior chamber; however, the former is asymptomatic,
whereas the latter is symptomatic. In any case, both glaucomas
share a final pathway involving the formation of irreversible
synechial adhesion between the peripheral iris and the TM [34].
In closed-angle glaucomas, the TM is obstructed by the iris, which
prevents TM cells from functioning, thereby impeding the normal
flow of aqueous humor across this region. The duration of contact
closure necessary to cause synechial closure appears to vary greatly
from patient to patient. If the obstacle to outflow is promptly
removed, IOP may return to normal values. However, prolonged
contact between the iris or iris/lens and the TM may lead to
permanent damage to TM functionality and produce a permanent
IOP increase.
In congenital and juvenile glaucoma, there are several
pathogenic factors that come into play, spanning from arrested
development of the anterior chamber angle structures, which is
characterized by incomplete maturation of the TM and
Schlemm’s canal [35], to mesodermal dysgenesis of the iris and
cornea characterized by abnormalities of the anterior chamber
cleavage [36] and from congenital hereditary endothelial dystro-
phy [37] to arginase deficit [38]. The increased resistance to
aqueous humor outflow in congenital glaucoma may stem from
abnormalities of the TM and the internal wall of Schlemm’s canal
[39]. It is possible that both congenital and juvenile glaucoma
occur because of developmental immaturity of the TM in anterior
chamber angle tissues [40]. Ultrastructural examination of TM
shows that the inner cribriform area is greatly thickened and the
amount of sheath-derived plaque material is increased in the
subendothelial layer adjacent to Schlemm’s canal [41]; there are
no vacuoles in the endothelium of Schlemm’s canal, and there is a
broad layer of collagen and amorphous material in the
Table 1. Mitochondrial DNA damage detected in TM of various glaucoma types.
Disease status Age (years)
mtDNA deletion amount
(%mtDNA deletion/mtDNA)
Mitochondrial number
(mtDNA/mg wet tissue)
TM cell number (nDNA/mg
wet tissue)
Oxidative nDNA
damage (8-oxo-dG/105
nucleotides)
Controls
N=16
65612 12.965.1 18.761.6 9.161.6 2.362.5
POAG
n=16
71693 8 . 7 621.8* 2.960.5* 0.560.1* 8.064.2*
PEXG
n=5
72648 2 . 1 639.0* 0.160.0* 0.160.1* 9.863.7*
PG
n=2
36614 5.064.1 3.563.2 0.760.5* NT
JG
n=4
4362 2.761.3 0.760.6* 0.160.1* 3.062.8
CG
n=4
21610 0.360.1 0.960.4* 0.260.1* 1.560.4
ACG
n=3
6062 0.960.8 4.162.4* 0.960.7* 2.861.0
NvG
n=2
7064 0.160.0 4.760.7* 0.760.3* 3.261.2
CCAG
n=2
6462 0.460.3 1.861.5* 3.363.1* 2.160.4
*P,0.05 compared to controls.
doi:10.1371/journal.pone.0014567.t001
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of proteoglycans in the goniodsygenetic trabecular tissues are
virtually the same as in normal tissues [43], and there are no
significant differences between the morphological picture of
primary congenital glaucoma and that found in Axenfeld and
Rieger anomalies [44]. Accordingly, the pathogenesis of all these
glaucoma types does not require the occurrence of mitochondrial
damage, as demonstrated by the data reported here.
The lack of mitochondrial deletion was also confirmed in the
cases of pigmentary glaucoma. In this situation, the development
of the chronic glaucomatous condition cannot be directly
attributed to pigment accumulation in the juxtacanalicular tissue
[45]. However, many TM alterations have been described: loss of
trabecular cells, fusion of trabecular lamellae and collapse of
intertrabecular spaces, increase in extracellular material, and
obliteration of the canal have been found to varying degrees
around the circumference of eyes with pigment dispersion
syndrome and elevated intraocular pressure and in pigmentary
glaucoma. These probably all contribute to the development of
increased intraocular pressure in pigmentary glaucoma [46].
Macrophages are the main cell type responsible for TM clearance
of pigment and debris [47]. It is possible that, on a genetic basis,
they play a central role in the pathophysiology of pigmentary
glaucoma.
In conclusion, our findings demonstrate that in all types of
glaucoma in which IOP is high, TM malfunction resulting from
cellularity decrease is the key to the development of the disease.
However, only in primary open angle and pseudo-exfoliation
glaucoma was mitochondrial damage detected, as the outflow
dysfunction in the other glaucomas studied may have a different
underlying basis.
Materials and Methods
Patient recruitment and sample collection
Between January 2007 and July 2009, 38 consecutive glaucoma
patients (21 women, 17 men) aged 55–82 years (7067.15 years,
mean 6 SE) were enrolled. They included 16 cases of primary
open-angle (POAG), 2 pigmented (PG), 4 juvenile (JG), 4
congenital (CG), 5 pseudoexfoliative (PEXG), 3 acute (ACG), 2
neovascular (NvG), and 2 chronic closed-angle (CCAG) glaucoma.
Various glaucoma diagnosis were performed on a clinical basis.
Both NVG patients were suffering from systemic hypertension and
both have had a thrombosis of central vein of the retina.
Glaucoma was diagnosed and classified on the basis of clinical
characteristics (slit-lamp examination, gonioscopy, intraocular
pressure (IOP) increase, pachymetry, perimetric test and optic
nerve morphometric or nerve fiber layer analysis with GDx or
HRT) according to the classification of Shields, Ritch and Krupin
[48]. GDx-VCC software version 5.2.3 (Laser Diagnostic
Technologies, San Diego, CA) was used to evaluate the
parapapillary RNFL. Confocal scanning laser ophthalmoscopy
was performed with the Heidelberg Retina Tomograph II and
analyzed with HRT III software (Heidelberg Engineering GmbH,
Heidelberg, Germany). Visual-field testing was performed with the
Humphrey Field Analyzer 750 (Allergan Humphrey, San
Leandro, CA). The presence of perimetric glaucomatous defects
was assessed by computerized visual-field testing (Humphrey 30-2
computerized visual-field examination) and graded according to
the criteria proposed by Caprioli [49]. A visual-field defect score
was assigned according to Brusini and Tosoni [50]. The study
adhered to the tenets of the Declaration of Helsinki and was
approved by the Ethical Board of the Ophthalmologic Division.
The glaucoma patients, after having provided written informed
consent, underwent ocular filtration surgery for therapeutic
purposes. Trabeculectomy specimens were collected at surgery
from the 38 glaucomatous patients. For each patient, we
considered only one eye with an established diagnosis of POAG
showing failed tonometric compensation and worsening of
perimetric and optic disc conditions. All patients were treated
with maximal therapy, including prostaglandin F2 analogs (92.1%
[35 patients]), systemic carbonic anhydrase inhibitors (86.8% [33
patients]), topical beta-blockers (84.2% [32 patients]), topical
carbonic anhydrase inhibitors (84.2% [32 patients]), a2-agonists
(76.3% [29 patients]), and pilocarpine (28.9% [11patients]).
Despite using the maximal tolerated therapy, all patients showed
elevated IOP on entry to the hospital department (min 25 mmHg;
max 41 mmHg; mean 31.364.62). Patients underwent ocular
filtration surgery for therapeutic purposes at the Ophthalmology
Unit of S. Martino Hospital in Genoa from 2007 to 2009. Samples
were collected by standard surgical trabeculectomy as previously
described [5–9]. Inclusion criteria were the presence of glaucoma
with no tonometric compensation and the absence of any other
ocular, systemic or neurological diseases other than optic nerve
damage.
As control samples, we used trabeculectomy and iris specimens
collected from 16 subjects aged 66.161.27 years who were gender-
matched with patients. These samples were provided by the
Melvin Jones Eye Bank in Genoa from 2007 to 2009. The control
samples had been obtained immediately after death from
glaucoma-free subjects undergoing eye removal for cornea
transplantation, as previously described [9]. Every effort was
made to ensure that the sampling times in donors were the same as
in the patients studied. Control samples were taken no later than
1 hour after death, thus ensuring cell viability, which is obviously
very important in cornea transplantation. Samples were immersed
in stabilizing buffers containing antioxidants and stored at 280uC
until DNA purification, which was performed with proteinase K
and solvent extraction in an oxygen-free atmosphere, as previously
described [9].
Approval for this study was given by the Ethics Committee of
the Ophthalmologic Unit of the Head/Neck Department of San
Martino Hospital, Genoa, Italy, and all study patients provided
written informed consent. The research followed the tenets of the
Declaration of Helsinki.
Detection of mitochondrial DNA damage
Mitochondrial DNA damage was evaluated in terms of the
common 4977-bp deletion, which is a large mtDNA deletion
involving the loss of almost one third of the mitochondrial genome.
To evaluate the frequency of the common 4977-bp deletion in
mtDNA, we performed two real-time QPCR reactions for each
sample, one aimed at detecting the amount of total mtDNA
(TMDQ) and one to quantify the deleted mtDNA (DMDQ). The
TMDQ evaluation was carried out by using two primers (tot mt S:
CCATCTTTGCAGGCACACTCATC and tot mt A: ATC-
CACCTCAACTGCCTGCTATG) flanking a sequence of mt
DNA known not to be susceptible to deletion [51] and an ad hoc–
designed FAM-labeled molecular beacon (mt tot: CGCGATCT-
CACGCAAGCAACCGCATCCATGATCGCG). The DMDQ
evaluation was performed using two primers (del mt S:
GGCCCGTATTTACCCTATAG and del mt A: GGTGAGAA-
GAATTATTCGAGTG) flanking the region susceptible to
deletion and a second ad hoc FAM-labeled molecular beacon (mt
del: CGCGATCCAGCCTAGCATTAGCAGGAATACCTT-
GATCGCG). Because of the short elongation time, only deleted
mtDNA can efficiently give rise to an amplicon containing the
target sequence for the mt del molecular beacon. DNA for TMDQ
Glaucoma Mitochondria Deletion
PLoS ONE | www.plosone.org 5 January 2011 | Volume 6 | Issue 1 | e14567quantification was diluted 10-fold more than for DMDQ. The
reaction conditions were 5 ml 10x PCR buffer, 0.4 ml 100 mM
dNTP mix, 2 ml 50 mM MgCl2, 0.5 ml Platinum Taq DNA
polymerase (Invitrogen Corporation, Carlsbad, CA), 37.1 ml sterile
water, 1 ml 10 mM sense primer, 1 ml 10 mM anti-sense primer,
2 ml molecular beacon, and 1 ml DNA. The mixture was split into
two 200-ml flat-cap transparent tubes.
The reactions were performed in a Rotorgene 3000 (Corbett
Research, Mortlake NSW 2137, Australia) as follows: 94uC for
2 min, followed by 45 cycles at 94uC for 30 sec, room temperature
for 30 sec, and 72uC for 30 sec. The FAM channel was acquired
at the end of the annealing step. The annealing temperature for mt
tot was 54uC and for mt del 51uC.
The del-mtDNA/tot-mtDNA ratio was assessed for each sample
and normalized to the number of cells and to the quantitiy of
nuclear DNA, as assessed by a further QPCR reaction quantifying
the housekeeping gene GAPDH.
Primer sequences and PCR conditions were determined by
using Beacon Designer 6.0 software (Premier Biosoft International,
Palo Alto, CA). Result specificity was checked by analyzing the
melting curves of PCR products.
The relative amount of total nuclear DNA in each sample was
evaluated by quantifying the copies of GAPDH mRNA by means
of quantitative real-time PCR (QPCR). This parameter was
compared both to the number of mitochondrial DNA copies
(nuclear/mitochondrial DNA ratio) and to the amount of wet
tissue processed (DNA/g wet tissue). This last parameter was taken
as an indicator of TM cellularity. The following primers and the
molecular beacon specific for a 149-bp DNA sequence of human
GAPDH were designed with Beacon Designer and purchased
from TIB (Molbiol, Berlin, Germany): Sense TGTCTGCT-
TCTCTGCTGTAG, Anti-sense CTGCCTTCCTCACCT-
GATG, Probe 59 – FAM – CGCGATCCATGTTCGTCAT-
GGGTGTGAACCAGATCGCG – BHQ1.
The QPCR reaction was carried out in a rotating real-time
thermocycler (Corbett Life Science, Sydney, Australia) in a
mixture containing 0.1 mg DNA, 0.2 mM each of ATP, GTP,
TTP and CTP, 1.5 mM MgCl2, 2 U Platinum Taq DNA
polymerase, 0.2 mM primer Sense, 0.2 mM primer Anti-sense,
0.4 mm Probe and water to 50 ml. Polymerase was hot start–
activated at 94uC for 2 min, and 40 amplification cycles of 94uC
for 40 sec, 53uC for 30 sec and 72uC for 30 sec followed. The
fluorescent signal was detected at every annealing step.
Relative quantification was performed by comparing the cycle
threshold of every sample with that of a standard dilution of a
DNA sample of known concentration.
Detection of oxidative DNA damage to nuclear DNA
Oxidative DNA damage was analyzed in terms of 8-hydroxy-29-
deoxyguanosine (8-oxo-dG) by
32P-postlabeling as previously
reported [9].
Statistical analyses
Comparisons of quantitative variables among different groups
were performed by ANOVA and Student’s t test for unpaired data
after checking the normality of the distribution by kurtosis skew
analysis. The accepted level of significance in all cases was
P,0.05. In the case of non-normal distribution of data, non-
parametric Mann-Whitney U and Kruskal-Wallis tests were used.
Correlations between continuous variables were tested by linear
regression analysis. Differences in frequency distributions among
nominal variables were tested by the chi-square test. All statistical
analyses were performed with the Statview software (Abacus
Concepts, Berkeley, CA).
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